Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

Published:2018-12 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Boilève A.,Carlo M. I.,Barthélémy P.,Oudard S.,Borchiellini D.,Voss M. H.,George S.,Chevreau C.,Landman-Parker J.,Tabone M-D,Chism D. D.,Amin A.,Bilen M. A.,Bosse D.,Coulomb-L’hermine A.,Su Xiaoping,Choueiri T. K.,Tannir Nizar M.,Malouf Gabriel G.

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0482-z.pdf

Reference28 articles.

1. Kauffman EC, Ricketts CJ, Rais-Bahrami S, et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol. 2014;11(8):465.

2. Delahunt B, Srigley JR, Egevad L, et al. International Society of Urological Pathology grading and other prognostic factors for renal neoplasia. Eur Urol. 2014;66(5).

3. Classe M, Malouf GG, Su X, et al. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas. Histopathology. 2017;70(7):1089–97.

4. Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009;15(4):1170–6.

5. Zhong M, De Angelo P, Osborne L, et al. Translocation renal cell carcinomas in adults: a single institution experience. Am J Surg Pathol. 2012;36(5):654.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma;The Journal of Pathology;2024-08-02

2. Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma;Experimental & Molecular Medicine;2024-08-01

3. A genetic basis for sex differences in Xp11 translocation renal cell carcinoma;Cell;2024-08

4. Understanding the role of BRD8 in human carcinogenesis;Cancer Science;2024-07-05

5. The New WHO Category of “Molecularly Defined Renal Carcinomas”: Clinical and Diagnostic Features and Management Implications;Urologic Oncology: Seminars and Original Investigations;2024-07